FedEx Floor to decreased holiday quantity forecasts – inner memo

FedEx Floor to decreased holiday quantity forecasts – inner memo


A female walks past FedEx Corp. Floor car or truck parked in the Midtown neighborhood of New York, U.S., on Friday, Dec. 4, 2015.

John Taggart | Bloomberg | Getty Images

LOS ANGELES – The FedEx Corp division that handles most of the company’s e-commerce deliveries ideas to decreased volume forecasts for the reason that its consumers prepare to ship fewer getaway deals, according to an internal memo acquired by Reuters.

The message to the 6,000 independent contractors that manage shipping and delivery and trucking for FedEx Floor in the United States and Canada came about two weeks just after the worldwide transport business pulled its full-year forecast and announced an unexpected first-quarter financial gain fall of much more than 20%.

Shares in FedEx fell 2.7% to $151.05 on the news on Friday.

“We assume there to be downward adjustments to quantity forecasts,” Paul Melander, a FedEx Floor senior vice president stated in the message to the unit’s supply contractors before this 7 days. The new forecasts will be available on or about Oct. 21.

“These alterations will reflect the newest information and facts from consumers about how they foresee current problems are very likely to decrease their volumes this holiday getaway season,” Melander said.

FedEx did not quickly reply to requests for comment.

The company’s Ground division contributes additional than 40% of its running profits. More than a dozen contractors advised Reuters that their volumes had been down anyplace from 5% to 15% this yr versus the similar time in 2021.



Supply

Merck shells out  billion for London-based lung therapy firm Verona
World

Merck shells out $10 billion for London-based lung therapy firm Verona

Bloomberg | Bloomberg | Getty Images Merck will buy UK-based Verona Pharma for about $10 billion, the companies said on Wednesday, strengthening the U.S. firm’s respiratory treatment portfolio in a bid to diversify its revenue source beyond blockbuster cancer drug. Merck has been leaning on its aging cancer immunotherapy Keytruda, the world’s top-selling prescription medicine, […]

Read More
Singapore state investor Temasek is rethinking defense as a strategic ESG bet
World

Singapore state investor Temasek is rethinking defense as a strategic ESG bet

Defense stocks are booming — and according to one of Asia’s biggest investors, allocating capital to the sector doesn’t mean having to abandon ESG initiatives. Speaking to CNBC’s Martin Soong on Wednesday, Rohit Sipahimalani, chief investment officer at Singapore’s state investment fund Temasek, said his team were looking at opportunities in the European defense sector. […]

Read More
Shares of Ray-Ban maker EssilorLuxottica jump 6% on reported Meta stake in AI push
World

Shares of Ray-Ban maker EssilorLuxottica jump 6% on reported Meta stake in AI push

Smart Ray-Ban Glasses, on June 16, 2024, in Caen, Normandy, France. Nurphoto | Getty Images Shares of Ray-Ban maker EssilorLuxottica almost 6% on Wednesday on reports that Meta has taken a minority stake in the company amid growing appetite for AI-powered wearable devices. Meta reportedly bought a stake worth around 3 billion euros ($3.51 billion) […]

Read More